CYP2C19 and Hepatic failure: Therefore, it is crucial to focus on the impact of CYP2C19, CYP3A4, and CYP2C9 gene phenotypes in hepatic insufficiency patients on VRZ plasma concentrations, as this holds positive implications for the successful treatment of hepatic insufficiency with concomitant invasive fungal infections.